The Impact of CRISPR-Cas System on Antiviral Therapy

Hadi Bayat ^1,2 , Fatemeh Naderi ³ , Amjad Hayat Khan ⁴ , Arash Memarnejadian ⁵ , Azam Rahimpour ¹ *

Cited by CrossRef: 25

1- Vilela J, Rohaim M, Munir M. Application of CRISPR/Cas9 in Understanding Avian Viruses and Developing Poultry Vaccines. Front Cell Infect Microbiol. 2020;10 [Crossref]

2- Mohanty B, Ahmad Mir R, Priyadarshini A, Ahmad Bhat K, Barati S, Roshani Asl E, Choi J, Rasmi Y. Potential use of CRISPR/Cas13 system for vaccine development against various RNA-viral infections . Future Virology. 2024;19(10-11):401 [Crossref]

3- Karimian A, Gorjizadeh N, Alemi F, Asemi Z, Azizian K, Soleimanpour J, Malakouti F, Targhazeh N, Majidinia M, Yousefi B. CRISPR/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases. Life Sciences. 2020;259:118165 [Crossref]

4- Siegrist C, Kinahan S, Settecerri T, Greene A, Santarpia J. CRISPR/Cas9 as an antiviral against Orthopoxviruses using an AAV vector. Sci Rep. 2020;10(1) [Crossref]

5- DEMİREL S, USTA M, DEMİREL F. Fitopatojenlere Karşı Dayanıklılıkta CRISPR/Cas Teknolojisi. 2020; [Crossref]

6- Najafi S, Tan S, Aghamiri S, Raee P, Ebrahimi Z, Jahromi Z, Rahmati Y, Sadri Nahand J, Piroozmand A, Jajarmi V, Mirzaei H. Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections. Biomedicine & Pharmacotherapy. 2022;148:112743 [Crossref]

7- Xu Y, Li Z. CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy. Computational and Structural Biotechnology Journal. 2020;18:2401 [Crossref]

8- Zahedipour F, Zahedipour F, Zamani P, Jaafari M, Sahebkar A. Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications. Virus Research. 2024;341:199314 [Crossref]

9- Gupta R, Kazi T, Dey D, Ghosh A, Ravichandiran V, Swarnakar S, Roy S, Biswas S, Ghosh D. CRISPR detectives against SARS-CoV-2: a major setback against COVID-19 blowout. Appl Microbiol Biotechnol. 2021;105(20):7593 [Crossref]

10- Bellizzi A, Ahye N, Jalagadugula G, Wollebo H. A Broad Application of CRISPR Cas9 in Infectious Diseases of Central Nervous System. J Neuroimmune Pharmacol. 2019;14(4):578 [Crossref]

11- Bayat H, Mirahmadi M, Azarshin Z, Ohadi H, Delbari A, Ohadi M. CRISPR/Cas9-mediated deletion of a GA-repeat in human GPM6B leads to disruption of neural cell differentiation from NT2 cells. Sci Rep. 2024;14(1) [Crossref]

12- Hasanzadeh A, Alamdaran M, Ahmadi S, Nourizadeh H, Bagherzadeh M, Mofazzal Jahromi M, Simon P, Karimi M, Hamblin M. Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies. Journal of Controlled Release. 2021;336:354 [Crossref]

13- Shams F, Bayat H, Mohammadian O, Mahboudi S, Vahidnezhad H, Soosanabadi M, Rahimpour A. Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems. Bioimpacts. 2022;12(4):371 [Crossref]

14- Panda K, Alagarasu K, Parashar D. Oligonucleotide-Based Approaches to Inhibit Dengue Virus Replication. Molecules. 2021;26(4):956 [Crossref]

15- Souri M, Chiani M, Farhangi A, Mehrabi M, Nourouzian D, Raahemifar K, Soltani M. Anti-COVID-19 Nanomaterials: Directions to Improve Prevention, Diagnosis, and Treatment. Nanomaterials. 2022;12(5):783 [Crossref]

16- Khurana A, Sayed N, Singh V, Khurana I, Allawadhi P, Rawat P, Navik U, Pasumarthi S, Bharani K, Weiskirchen R. A comprehensive overview of CRISPR/Cas 9 technology and application thereof in drug discovery. J of Cellular Biochemistry. 2022;123(10):1674 [Crossref]

17- Ullah A, Khan M, Akram M, Abdullah M, Sayka S, Iqbal I, Siddique F, Arain M, Hassan F, Shafi M. CRISPR Cas-9 for treatment and control of Avian viral diseases: challenges and opportunities. World's Poultry Science Journal. 2024;80(3):745 [Crossref]

18- Kumar P, Malik Y, Ganesh B, Rahangdale S, Saurabh S, Natesan S, Srivastava A, Sharun K, Yatoo M, Tiwari R, Singh R, Dhama K. CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics. Front Cell Infect Microbiol. 2020;10 [Crossref]

19- Le T, Paris C, Khan K, Robson F, Ng W, Rocchi P. Nucleic Acid-Based Technologies Targeting Coronaviruses. Trends in Biochemical Sciences. 2021;46(5):351 [Crossref]

20- Lou J, Wang B, Li J, Ni P, Jin Y, Chen S, Xi Y, Zhang R, Duan G. The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases. Mol Biol Rep. 2022;49(12):11301 [Crossref]

21- Abdeldayem O, Dabbish A, Habashy M, Mostafa M, Elhefnawy M, Amin L, Al-Sakkari E, Ragab A, Rene E. Viral outbreaks detection and surveillance using wastewater-based epidemiology, viral air sampling, and machine learning techniques: A comprehensive review and outlook. Science of The Total Environment. 2022;803:149834 [Crossref]

22- Dehshahri A, Biagioni A, Bayat H, Lee E, Hashemabadi M, Fekri H, Zarrabi A, Mohammadinejad R, Kumar A. Editing SOX Genes by CRISPR-Cas: Current Insights and Future Perspectives. IJMS. 2021;22(21):11321 [Crossref]

23- Kim J, Koo B, Yoon K. Modeling Host-Virus Interactions in Viral Infectious Diseases Using Stem-Cell-Derived Systems and CRISPR/Cas9 Technology. Viruses. 2019;11(2):124 [Crossref]